Chandan Healthcare logo

Chandan Healthcare financials and balance sheet

NSE: CHANDANHealthcare Services

Last close ₹218.60down ₹10.40 (4.54%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹229.00.

52-week range of traded prices to 23 Oct 2026
₹185.40Low, 19 Jun 2026₹358.00High, 18 Nov 2025
Market cap
₹562 Cr
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, NSE
36,00062.2% delivered

2 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Chandan Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹276 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue276
  2. Depreciation−9.8
  3. Other income+4.3
  4. Finance costs−5.9
  5. Profit before tax38
  6. Net profit27

What the company owns

  • Plant, investments and other assets₹154 Cr
  • Receivables₹86 Cr
  • Inventory₹34 Cr
  • Current investments₹12 Cr
  • Cash and bank₹4 Cr

What pays for it: net worth and liabilities

  • Net worth₹176 Cr
  • Borrowings₹54 Cr
  • Owed to suppliers₹41 Cr
  • Other liabilities₹19 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Chandan Healthcare quarterly results

₹ croreMar 2025Filed 28 MayMar 2026Filed 25 Jun
Revenue from operations230276
189–
Materials and goods bought108134
Employee costs39–
Other expenses42–
Operating profit before depreciation41–
Operating margin18.0%–
Materials, % of revenue46.8%–
Employee costs, % of revenue16.9%–
Other expenses, % of revenue18.4%–
Depreciation and amortisation710
Operating profit after depreciation35–
Other income24
Finance costs56
Profit before one-off items and tax3241
Profit before tax3238
Net profit2227
Net margin9.6%9.8%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2026: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2025Filed 28 MayMar 2026Filed 25 Jun
126176
123171
Share capital24–
Reserves98–
Belonging to outside owners of subsidiaries45
4854
5777
2736
Total assets211290
100125
110165
Net debt4238
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2025Filed 28 MayMar 2026Filed 25 Jun
−29.116.2
−20.525.9
−63.0−25.7
Receivables−17.0−39.2
Inventories−13.4−2.4
Payables5.415.0
Other working capital−38.11.0
Tax paid−8.5−9.7
Capital spending38.742.6
Free cash flow−67.8−26.4
−35.7−39.9
67.121.1
Dividends paid3.00.0
Shares issued62.30.0
Net change in cash2.3−2.6
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2025Filed 28 MayMar 2026Filed 25 Jun
Earnings per share₹10.78₹11.07
Diluted earnings per share₹10.78₹10.76
Book value per share₹50.14₹69.93
Shareholder yield−13.4%0.0%
Market cap at the year end (₹ crore)443536

Ratios

Consolidated, years to March.Chandan Healthcare PE ratio and valuation

RatioMar 2025Filed 28 MayMar 2026Filed 25 Jun
Revenue growth–20.1%
Net profit growth–22.0%
Earnings per share growth–2.7%
18.1%18.4%
–0.3 pts
From the net margin–0.3 pts
From asset turnover–0.2 pts
From borrowing–−0.2 pts
Return on capital employed19.8%–
Cash conversion−131.0%59.8%
Interest cover7.6–
Debt to equity0.380.30
Receivable days74114
Inventory days10692
Payable days87112
Cash conversion cycle, days9395
Working capital days116127
Asset turnover1.091.11
Assets per rupee of net worth1.721.70
Sales per rupee of plant3.202.86
Capital spending to depreciation5.744.35

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
10.8%
Measure3 years
Return on equity, average18.3%
Net margin, average9.7%
Asset turnover, average1.10
Cash conversion cycle, days, average94
Debt to equity, average0.34

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations16.2
Cash from investing−39.9
Cash from financing21.1
Capital spending42.6
Dividends paid0.0
Shares issued for cash0.0
Borrowings raised5.6
Borrowings repaid0.0

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points–64.92
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−16.67
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–1.03
Effective tax ratePublished threshold 17.16 per cent26.6625.38
Tax charged less tax paid, % of profitOur threshold 10 percentage points0.000.00
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
17 Aug 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BBB-/Watch DevelopingRating continues on Watch Developing2
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.